Increased TGFβ /Activin-Smad2 signaling is associated with pancreatic β-cell dysfunction and glucose intolerance in gestational diabetes mellitus
Talía Boronat‐Belda, Hilda Ferrero, Sergi Soriano, Elena Ribes-García, R Betoret Gustems, Daniel Martínez-Bañón, Mónica Serrano-Selva, Juan Martínez‐Pinna, Ángel Nadal, Iván Quesada, Paloma Alonso‐Magdalena
This study identifies increased TGFβ/Activin-Smad2 signaling in GDM as a contributor to β-cell dysfunction and glucose intolerance, with pharmacological inhibition showing therapeutic potential.
Molecular Metabolism · Oct 18, 2025Peer-reviewedPhysiology